vs
Side-by-side financial comparison of IMAX CORP (IMAX) and Syndax Pharmaceuticals Inc (SNDX). Click either name above to swap in a different company.
IMAX CORP is the larger business by last-quarter revenue ($125.2M vs $68.5M, roughly 1.8× Syndax Pharmaceuticals Inc). IMAX CORP runs the higher net margin — 0.5% vs -99.3%, a 99.8% gap on every dollar of revenue. On growth, Syndax Pharmaceuticals Inc posted the faster year-over-year revenue change (791.7% vs 35.1%).
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
Syndax Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative oncology therapies for patients with hard-to-treat cancers. Its pipeline includes targeted and immunotherapy candidates addressing unmet medical needs, primarily serving global oncology healthcare stakeholders and patient populations.
IMAX vs SNDX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $125.2M | $68.5M |
| Net Profit | $637.0K | $-68.0M |
| Gross Margin | 57.6% | — |
| Operating Margin | 19.3% | -91.3% |
| Net Margin | 0.5% | -99.3% |
| Revenue YoY | 35.1% | 791.7% |
| Net Profit YoY | -88.0% | 27.8% |
| EPS (diluted) | $0.02 | $-0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $125.2M | $68.5M | ||
| Q3 25 | $106.7M | $45.9M | ||
| Q2 25 | $91.7M | $38.0M | ||
| Q1 25 | $86.7M | $20.0M | ||
| Q4 24 | $92.7M | — | ||
| Q3 24 | $91.5M | $12.5M | ||
| Q2 24 | $89.0M | — | ||
| Q1 24 | $79.1M | $0 |
| Q4 25 | $637.0K | $-68.0M | ||
| Q3 25 | $20.7M | $-60.7M | ||
| Q2 25 | $11.3M | $-71.8M | ||
| Q1 25 | $2.3M | $-84.8M | ||
| Q4 24 | $5.3M | — | ||
| Q3 24 | $13.9M | $-84.1M | ||
| Q2 24 | $3.6M | — | ||
| Q1 24 | $3.3M | $-72.4M |
| Q4 25 | 57.6% | — | ||
| Q3 25 | 63.1% | — | ||
| Q2 25 | 58.5% | — | ||
| Q1 25 | 61.4% | — | ||
| Q4 24 | 52.2% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 49.4% | — | ||
| Q1 24 | 59.3% | — |
| Q4 25 | 19.3% | -91.3% | ||
| Q3 25 | 27.2% | -125.2% | ||
| Q2 25 | 15.6% | -182.7% | ||
| Q1 25 | 19.3% | -417.9% | ||
| Q4 24 | 10.3% | — | ||
| Q3 24 | 21.2% | -716.6% | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 15.3% | — |
| Q4 25 | 0.5% | -99.3% | ||
| Q3 25 | 19.4% | -132.4% | ||
| Q2 25 | 12.3% | -189.3% | ||
| Q1 25 | 2.7% | -423.3% | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 15.2% | -673.0% | ||
| Q2 24 | 4.0% | — | ||
| Q1 24 | 4.1% | — |
| Q4 25 | $0.02 | $-0.78 | ||
| Q3 25 | $0.37 | $-0.70 | ||
| Q2 25 | $0.20 | $-0.83 | ||
| Q1 25 | $0.04 | $-0.98 | ||
| Q4 24 | $0.09 | — | ||
| Q3 24 | $0.26 | $-0.98 | ||
| Q2 24 | $0.07 | — | ||
| Q1 24 | $0.06 | $-0.85 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $151.2M | $394.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $337.9M | $64.6M |
| Total Assets | $894.0M | $529.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $151.2M | $394.1M | ||
| Q3 25 | $143.1M | $436.0M | ||
| Q2 25 | $109.3M | $455.2M | ||
| Q1 25 | $97.1M | $512.2M | ||
| Q4 24 | $100.6M | — | ||
| Q3 24 | $104.5M | $389.6M | ||
| Q2 24 | $91.6M | — | ||
| Q1 24 | $81.0M | $434.6M |
| Q4 25 | $337.9M | $64.6M | ||
| Q3 25 | $349.5M | $115.4M | ||
| Q2 25 | $320.4M | $157.4M | ||
| Q1 25 | $299.5M | $215.1M | ||
| Q4 24 | $299.5M | — | ||
| Q3 24 | $289.4M | $366.4M | ||
| Q2 24 | $267.2M | — | ||
| Q1 24 | $258.8M | $491.9M |
| Q4 25 | $894.0M | $529.7M | ||
| Q3 25 | $889.6M | $551.8M | ||
| Q2 25 | $868.6M | $596.1M | ||
| Q1 25 | $848.3M | $640.7M | ||
| Q4 24 | $830.4M | — | ||
| Q3 24 | $847.6M | $425.8M | ||
| Q2 24 | $827.4M | — | ||
| Q1 24 | $824.1M | $543.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.4M | $-69.5M |
| Free Cash FlowOCF − Capex | $28.0M | — |
| FCF MarginFCF / Revenue | 22.3% | — |
| Capex IntensityCapex / Revenue | 1.1% | — |
| Cash ConversionOCF / Net Profit | 46.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $118.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.4M | $-69.5M | ||
| Q3 25 | $67.5M | $-70.5M | ||
| Q2 25 | $23.2M | $-87.8M | ||
| Q1 25 | $7.0M | $-95.2M | ||
| Q4 24 | $11.5M | — | ||
| Q3 24 | $35.3M | $-62.3M | ||
| Q2 24 | $35.0M | — | ||
| Q1 24 | $-11.0M | $-83.5M |
| Q4 25 | $28.0M | — | ||
| Q3 25 | $64.8M | — | ||
| Q2 25 | $20.9M | — | ||
| Q1 25 | $5.3M | — | ||
| Q4 24 | $6.9M | — | ||
| Q3 24 | $34.2M | — | ||
| Q2 24 | $33.5M | — | ||
| Q1 24 | $-12.1M | — |
| Q4 25 | 22.3% | — | ||
| Q3 25 | 60.7% | — | ||
| Q2 25 | 22.8% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 37.6% | — | ||
| Q1 24 | -15.3% | — |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 46.11× | — | ||
| Q3 25 | 3.27× | — | ||
| Q2 25 | 2.06× | — | ||
| Q1 25 | 2.99× | — | ||
| Q4 24 | 2.16× | — | ||
| Q3 24 | 2.54× | — | ||
| Q2 24 | 9.78× | — | ||
| Q1 24 | -3.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
SNDX
Segment breakdown not available.
